Skip to main content
https://pbs.twimg.com/media/DqO06K3WsAAKKKA.jpg
Strong ACR20 W16 response after Filgotinib in PsA (16.9% TNFi failures) #ACR18 @rheumnow https://t.co/kmOSQVRYdD
Julio Gonzalez
Oct-24-2018
×